Table 2.
Stemness marker analyses in GSCs revealed different expression patterns among GBM patients.
Sample | Passage | CD15 | CD31 | CD34 | CD45 | CD133 | CD90 |
---|---|---|---|---|---|---|---|
GSC 2 | 10 | + | +++ | + | + | +++ | +++ |
GSC 3 | 4 | + | +++ | + | + | +++ | + |
GSC 9 | 4 | + | +++ | ++ | + | + | + |
GSC 10 | 4 | + | + | + | ++ | + | +++ |
GSC 15 | 4 | + | ++ | ++ | + | ++ | +++ |
GSC 33 | 4 | ++ | + | ++ | ++ | +++ | +++ |
GSC 56 | 4 | + | + | + | + | ++ | +++ |
GSC 60 | 5 | + | + | ++ | + | + | +++ |
GSC 85 | 4 | + | ++ | ++ | + | ++ | ++ |
GSC 90 | 6 | + | + | + | +++ | +++ | +++ |
+: 0-33%; ++: 34-66%; +++: 67-100%.